Tatavosian, Roubina
Donovan, Micah G.
Galbraith, Matthew D.
Duc, Huy N.
Szwarc, Maria M.
Joshi, Molishree U.
Frieman, Amy
Bilousova, Ganna
Cao, Yingqiong
Smith, Keith P.
Song, Kunhua
Rachubinski, Angela L.
Andrysik, Zdenek
Espinosa, Joaquin M. http://orcid.org/0000-0001-9048-1941
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL133230)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA046934, R01CA117907)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 15 July 2022
Revised: 3 January 2023
Accepted: 6 January 2023
First Online: 21 January 2023
Competing interests
: J.M.E. has provided consulting services for Elli Lily and Co. and Gilead Sciences Inc. and serves in the advisory board of Perha Pharmaceuticals.
: Biospecimens for iPSC generation were obtained through the Crnic Institute Human Trisome Project Biobank (NCT02864108). Sample collection was approved by the Colorado Multiple Institutional Review Board (COMIRB protocol #15-2170) and written consent was obtained from all participants or their legal guardians. The study was performed in accordance to the Declaration of Helsinki.